• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺功能正常恢复对女性内脂素浓度及身体成分的影响。

Effect of restoration of euthyroidism on visfatin concentrations and body composition in women.

作者信息

Sawicka-Gutaj Nadia, Zybek-Kocik Ariadna, Kloska Michał, Ziółkowska Paulina, Czarnywojtek Agata, Sowiński Jerzy, Mańkowska-Wierzbicka Dorota, Ruchała Marek

机构信息

Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland.

Lehigh Valley Health Network, Department of Medicine, Lehigh Valley Hospital - Cedar Crest, Allentown, USA.

出版信息

Endocr Connect. 2021 Apr 26;10(4):462-470. doi: 10.1530/EC-21-0059.

DOI:10.1530/EC-21-0059
PMID:33764900
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8111308/
Abstract

Dysregulation of thyroid function has known impact on body metabolism, however, data regarding metabolic outcome after restoration of thyroid function is limited. Therefore, the aim of the study was to investigate the effect of restoration of euthyroidism on serum visfatin, and its associations with insulin resistance and body composition. This is an observational study with consecutive enrollment. Forty-nine hyperthyroid (median age of 34 years) and 44 hypothyroid women (median age of 46 years) completed the study. Laboratory parameters and body composition analysis were assessed before and after the therapy. In the hyperthyroid group, visfatin concentrations increased (P < 0.0001), while glucose concentrations decreased (P < 0.0001). Total body mass and fat mass in the trunk and limbs significantly increased during the treatment. In the hypothyroid group, significant weight loss resulted from decrease of fat and muscle masses in trunk and limbs. Visfatin serum concentrations positively correlated with total fat mass (r = 0.19, P = 0.01) and insulin concentrations (r = 0.17, P = 0.018). In conclusion, restoration of thyroid function is not associated with beneficial changes in body composition, especially among hyperthyroid females.

摘要

甲状腺功能失调对身体代谢有已知影响,然而,关于甲状腺功能恢复后的代谢结果的数据有限。因此,本研究的目的是调查甲状腺功能恢复正常对血清内脂素的影响,及其与胰岛素抵抗和身体成分的关联。这是一项连续入组的观察性研究。49名甲状腺功能亢进女性(中位年龄34岁)和44名甲状腺功能减退女性(中位年龄46岁)完成了研究。在治疗前后评估实验室参数和身体成分分析。在甲状腺功能亢进组中,内脂素浓度升高(P < 0.0001),而血糖浓度降低(P < 0.0001)。治疗期间全身质量以及躯干和四肢的脂肪质量显著增加。在甲状腺功能减退组中,躯干和四肢的脂肪和肌肉质量减少导致体重显著下降。血清内脂素浓度与总脂肪质量(r = 0.19,P = 0.01)和胰岛素浓度(r = 0.17,P = 0.018)呈正相关。总之,甲状腺功能恢复与身体成分的有益变化无关,尤其是在甲状腺功能亢进女性中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa79/8111308/7c881e6a63df/EC-21-0059fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa79/8111308/bdb26b9a6cda/EC-21-0059fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa79/8111308/91b135af5e5c/EC-21-0059fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa79/8111308/765624f60df3/EC-21-0059fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa79/8111308/7c881e6a63df/EC-21-0059fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa79/8111308/bdb26b9a6cda/EC-21-0059fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa79/8111308/91b135af5e5c/EC-21-0059fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa79/8111308/765624f60df3/EC-21-0059fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa79/8111308/7c881e6a63df/EC-21-0059fig4.jpg

相似文献

1
Effect of restoration of euthyroidism on visfatin concentrations and body composition in women.甲状腺功能正常恢复对女性内脂素浓度及身体成分的影响。
Endocr Connect. 2021 Apr 26;10(4):462-470. doi: 10.1530/EC-21-0059.
2
Plasma visfatin concentrations increase in both hyper and hypothyroid subjects after normalization of thyroid function and are not related to insulin resistance, anthropometric or inflammatory parameters.甲状腺功能正常化后,甲状腺功能亢进和减退患者的血浆内脂素浓度均升高,且与胰岛素抵抗、人体测量学参数或炎症参数无关。
Clin Endocrinol (Oxf). 2009 Nov;71(5):733-8. doi: 10.1111/j.1365-2265.2009.03546.x. Epub 2009 Feb 16.
3
Nicotinamide phosphoribosyltransferase leukocyte overexpression in Graves' opthalmopathy.烟酰胺磷酸核糖基转移酶在Graves眼病患者白细胞中的过表达
Endocrine. 2016 Aug;53(2):497-504. doi: 10.1007/s12020-015-0855-8. Epub 2016 Jan 14.
4
Change of visfatin, C-reactive protein concentrations, and insulin sensitivity in patients with hyperthyroidism.甲状腺功能亢进患者内脂素、C反应蛋白浓度及胰岛素敏感性的变化
Metabolism. 2008 Oct;57(10):1380-3. doi: 10.1016/j.metabol.2008.05.006.
5
Association of circulating visfatin concentrations with insulin resistance and low-grade inflammation after dietary energy restriction in Spanish obese non-diabetic women: role of body composition changes.西班牙肥胖非糖尿病女性经饮食能量限制后循环内脂素浓度与胰岛素抵抗和低度炎症的相关性:与身体成分变化的关系。
Nutr Metab Cardiovasc Dis. 2012 Mar;22(3):208-14. doi: 10.1016/j.numecd.2010.06.010. Epub 2010 Oct 14.
6
Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.肝硬化患者血浆中PBEF/Nampt/内脂素水平降低。
Am J Physiol Gastrointest Liver Physiol. 2009 Feb;296(2):G196-201. doi: 10.1152/ajpgi.00029.2008. Epub 2008 Dec 12.
7
Plasma visfatin concentrations and fat depot-specific mRNA expression in humans.人体血浆内脂素浓度及脂肪储存部位特异性mRNA表达
Diabetes. 2005 Oct;54(10):2911-6. doi: 10.2337/diabetes.54.10.2911.
8
Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.慢性肾脏病患者中内脂素/前B细胞集落增强因子1的循环水平与基因型、肾小球滤过率、身体组成和生存率的关系
Am J Kidney Dis. 2007 Feb;49(2):237-44. doi: 10.1053/j.ajkd.2006.11.021.
9
Thyroid function and thyroid autoimmunity independently modulate serum concentration of soluble interleukin 2 (IL-2) receptor (sIL-2R) in thyroid diseases.甲状腺功能和甲状腺自身免疫分别调节甲状腺疾病中可溶性白细胞介素2(IL-2)受体(sIL-2R)的血清浓度。
Clin Endocrinol (Oxf). 1992 Nov;37(5):415-22. doi: 10.1111/j.1365-2265.1992.tb02352.x.
10
Activated (Ia+) T-cells and their subsets in Graves' disease and Hashimoto's thyroiditis using dual laser flow microfluorocytometric analysis.运用双激光流式微量荧光细胞分析法检测格雷夫斯病和桥本甲状腺炎中活化的(Ia +)T细胞及其亚群。
Mol Biol Med. 1986 Feb;3(1):99-112.

引用本文的文献

1
Retrospective Cross-Sectional Study of the Relationship of Thyroid Volume and Function with Anthropometric Measurements, Body Composition Analysis Parameters, and the Diagnosis of Metabolic Syndrome in Euthyroid People Aged 18-65.18-65 岁甲状腺功能正常人群的甲状腺体积和功能与人体测量学指标、身体成分分析参数的关系及与代谢综合征诊断的回顾性横断面研究
Medicina (Kaunas). 2024 Jun 30;60(7):1080. doi: 10.3390/medicina60071080.
2
Body composition changes in patients with differentiated thyroid cancer after iodine-131 treatment and short-term levothyroxine replacement and suppression therapy.分化型甲状腺癌患者碘-131 治疗及短期左甲状腺素替代与抑制治疗后体成分的变化。
Hormones (Athens). 2024 Jun;23(2):257-265. doi: 10.1007/s42000-024-00528-z. Epub 2024 Jan 26.
3

本文引用的文献

1
Peripheral levels of selected adipokines in patients with newly diagnosed multiple sclerosis.新诊断多发性硬化症患者外周血中选定脂肪因子的水平。
Endokrynol Pol. 2020;71(2):109-115. doi: 10.5603/EP.a2020.0008. Epub 2020 Mar 10.
2
The role of adipokines in the pathogenesis and course of selected respiratory diseases.脂肪细胞因子在某些呼吸系统疾病发病机制和病程中的作用。
Endokrynol Pol. 2019;70(6):504-510. doi: 10.5603/EP.a2019.0051.
3
Selected adipose tissue hormones in the blood of patients with ischaemic cerebral stroke.缺血性脑卒中患者血液中的选择性脂肪组织激素。
Safety of non-standard regimen of systemic steroid therapy in patients with Graves' orbitopathy: a single-centre experience.非标准全身类固醇治疗方案治疗格雷夫斯眼病患者的安全性:单中心经验。
Pharmacol Rep. 2024 Feb;76(1):185-194. doi: 10.1007/s43440-023-00567-0. Epub 2024 Jan 26.
4
Duration of antithyroid drug treatment may predict weight gain after radioactive iodine therapy in patients with Graves' disease.抗甲状腺药物治疗的时长可能预测格雷夫斯病患者放射性碘治疗后的体重增加情况。
Heliyon. 2022 May 18;8(5):e09471. doi: 10.1016/j.heliyon.2022.e09471. eCollection 2022 May.
5
Is eNAMPT/visfatin a potential serum marker of papillary thyroid cancer?烟酰胺磷酸核糖转移酶/内脂素是甲状腺乳头状癌潜在的血清标志物吗?
Ther Adv Endocrinol Metab. 2022 Apr 13;13:20420188221090005. doi: 10.1177/20420188221090005. eCollection 2022.
6
The Role of Thyroid Hormones on Skeletal Muscle Thermogenesis.甲状腺激素在骨骼肌产热中的作用。
Metabolites. 2022 Apr 7;12(4):336. doi: 10.3390/metabo12040336.
7
Interplay between Fatty Acid Binding Protein 4, Fetuin-A, Retinol Binding Protein 4 and Thyroid Function in Metabolic Dysregulation.脂肪酸结合蛋白4、胎球蛋白-A、视黄醇结合蛋白4与甲状腺功能在代谢失调中的相互作用
Metabolites. 2022 Mar 29;12(4):300. doi: 10.3390/metabo12040300.
Endokrynol Pol. 2020;71(1):21-26. doi: 10.5603/EP.a2019.0057. Epub 2019 Dec 18.
4
Thyroid Hormone Action and Energy Expenditure.甲状腺激素的作用与能量消耗。
J Endocr Soc. 2019 May 16;3(7):1345-1356. doi: 10.1210/js.2018-00423. eCollection 2019 Jul 1.
5
Weight gain following treatment of hyperthyroidism-A forgotten tale.甲状腺功能亢进症治疗后的体重增加——一个被遗忘的故事。
Clin Obes. 2019 Oct;9(5):e12328. doi: 10.1111/cob.12328. Epub 2019 Jul 3.
6
2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism.2018年欧洲甲状腺协会格雷夫斯甲亢管理指南。
Eur Thyroid J. 2018 Aug;7(4):167-186. doi: 10.1159/000490384. Epub 2018 Jul 25.
7
Determinants of Visfatin/NAMPT Serum Concentration and its Leukocyte Expression in Hyperthyroidism.甲状腺功能亢进症患者中内脂素/烟酰胺磷酸核糖转移酶血清浓度及其白细胞表达的影响因素。
Horm Metab Res. 2018 Sep;50(9):653-660. doi: 10.1055/a-0669-1584. Epub 2018 Sep 5.
8
Systemic Thyroid Hormone Status During Levothyroxine Therapy In Hypothyroidism: A Systematic Review and Meta-Analysis.甲状腺功能减退症患者左甲状腺素治疗期间的全身甲状腺激素状态:一项系统评价和荟萃分析。
J Clin Endocrinol Metab. 2018 Aug 15;103(12):4533-42. doi: 10.1210/jc.2018-01361.
9
Thyrotropin receptor, still much to be learned from the patients.促甲状腺激素受体,仍有许多需要从患者身上学习。
Best Pract Res Clin Endocrinol Metab. 2018 Apr;32(2):155-164. doi: 10.1016/j.beem.2018.03.002. Epub 2018 Mar 22.
10
Changes of Nicotinamide Phosphoribosyltransferase Expressions in Thyroid Glands of Patients with Different Thyroid Pathologies.不同甲状腺疾病患者甲状腺组织中烟酰胺磷酸核糖转移酶表达的变化。
Biomed Res Int. 2018 Feb 6;2018:1316390. doi: 10.1155/2018/1316390. eCollection 2018.